Visual Attention, Object Recognition, and Eye Movements in Healthy Volunteers

NCT07756853 | Not Yet Recruiting

• 2 other identifiers: 10002734002734-EI
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Background: Vision is vital for many of our daily activities. Researchers want to learn more about how we aim our eyes (that is, what images, such as faces, immediately attract our attention) and how we direct our attention (that is, what we see and what we ignore). Objective: To study how healthy adults process and respond to visual images. Eligibility: Healthy people aged 18 years with no vision problems. Design: Participants will have 5 to 10 clinic visits over 2 to 4 months. Some participants may have up to 25 visits. Each visit lasts about 1 hour. Participants will be screened. They will answer questions about their medical and eye history. They will have a standard eye exam; eye drops will be used to dilate the pupils. (They may skip this exam if they have had an eye exam at the NIH within the past year.) Participants will perform eye movement tests. They will sit in front of a computer and view images that appear on the screen. They may be asked to respond to what they see by speaking, moving their hands, looking in a certain direction, or pushing a button. Their eye movements will be tracked. For some tests, participants heads may be held steady using a chinrest and head strap. For some tests, they may wear a cap fitted with cameras that use invisible lights in front of their eyes.

Conditions

Healthy Volunteer

Keywords

Eye Movement; Visual Attention; Object Recognition

Outcome Measures

Primary Outcomes (1)

• Measurement of significant deviations in the trajectories or latencies of saccadic eye movements that are specific to basic features of socially relevant visual stimuli.

  By measuring the trajectory of eye movements made in the presence of socially relevant visual stimuli (e.g., faces) versus similar visual stimuli that are not socially relevant (e.g., houses), we will test how socially relevant stimuli can impact visual processes that are automatic and occur at very short latencies. Depending on the size of these eye movement measurement effects, we will obtain a sufficient number of observations per subject for each condition, and/or obtain observations from 10-30 subjects to verify the robustness and replicability of the outcomes.

  ongoing

Secondary Outcomes (1)

• Measurement of significant changes in the performance of visual attention tasks that depend on basic features of socially relevant visual stimuli.

  ongoing

Study Arms (1)

Healthy volunteers

Healthy adults, age 18 or older of either sex

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Healthy volunteer adults, over age 18, of either sex

You may qualify if:

• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Stated willingness to comply with all study procedures and actively pay attention to visual stimuli and respond as appropriate.
• Participant has visual acuity of 20/25 or better in both eyes.
• Participant must be 18 years old or older.
• Participant must understand and be willing to sign a written informed consent document.

You may not qualify if:

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Participant has an ocular, visual, or oculomotor problem that in the opinion of the Principal Investigator (PI) and/or clinical associate investigator would interfere with the participant s normal eye movements, visual perception, or required tasks.
• Participant has a history of eye patching (amblyopia or lazy eye).
• Participant has a non-ocular condition (e.g., neuropsychological conditions) that in the opinion of the PI and/or clinical associate investigator would interfere with the participant s normal eye movements or visual perception.

Sponsors & Collaborators

• National Eye Institute (NEI): lead
• National Institutes of Health Clinical Center (CC): collaborator

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

• NIH Clinical Center Detailed Web Page

Study Officials

• Rich J Krauzlis, Ph.D.

  National Eye Institute (NEI)

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ines E Espinal-Supp

CONTACT

(301) 496-9715; ines.espinal-supp@nih.gov

Rich J Krauzlis, Ph.D.

CONTACT

(301) 496-2455; richard.krauzlis@nih.gov

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 8, 2026
• First Posted: August 11, 2026
• Study Start (Estimated): August 16, 2026
• Primary Completion (Estimated): December 31, 2030
• Study Completion (Estimated): December 30, 2031
• Last Updated: August 11, 2026

Record last verified: 2026-08-03

Locations

US (1)